GlassScriptPhysician profile
Maureen C Holasek
NPI 1588660658
$2,859.75
in general payments reported to CMS, 2019-2025
45 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $926 · 2021: $1,066 · 2022: $268 · 2023: $91.29 · 2024: $27.04 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $416.15 | 2020-2025 | |
| Genzyme Corporation | $179.86 | 2019-2023 | |
| Seagen INC. | $162.58 | 2020-2021 | |
| Pfizer INC. | $153.70 | 2021-2022 | |
| Astellas Pharma US INC | $148.62 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $140.05 | 2021 | |
| Daiichi Sankyo INC. | $124.29 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $123.05 | 2019 | |
| Janssen Biotech, INC. | $113.62 | 2019-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $106.30 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $76.08 | 2019-2021 | |
| Emd Serono, INC. | $75.38 | 2020-2021 | |
| Teleflex LLC | $71.50 | 2025 | Barrigel |
| Accuray Incorporated | $67.34 | 2022 | |
| Celgene Corporation | $65.95 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Holasek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.